Ezra Rosen
Medical Oncology · Memorial Developmental Chemo Group
Credentials: · · · · ·
History
Columbia University Medical Center
Research
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2020 · 650 citations
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
Modern Pathology · 2020 · 431 citations
Tumour lineage shapes BRCA-mediated phenotypes
Nature · 2019 · 348 citations
- AD
16 papers
- ML
10 papers
- DH
7 papers
7 papers
- AS
6 papers
- DM
6 papers
- JH
6 papers
5 papers
Clinical trials
- 2021–2023
Principal investigator · Completed · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
- 2024–2026
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Site PI · Recruiting · Phase 1, Phase 2
858 Therapeutics, Inc.
- 2019–2025
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Site PI · Unknown · Phase 1, Phase 2
Effector Therapeutics